This week, Chuck Finney and guests take on the topic of employment law. Guests:  Employment Law attorneys:  Nina Fendel and Miles Locker, authors of "California Workers' Rights" published by U.C. Berkeley;  andMalcolm Loungway, an investigator with the federal Equal Employment Opportunity Commission, San Francisco office. 

On today's Your Call we’ll talk about education success stories.  With another round of severe budget cuts and a heated debate about education reform led by corporate funded think tanks, we’re taking a step back to talk about what’s actually working in our schools. Smaller class sizes? Textbooks that are more relevant to everyday life? More support for teachers?  Join us at 10 or email feedback@yourcallradio.org. What works in your local schools?  It’s Your Call with Holly Kernan, and you.

Guests

With his lopsided win in Florida, Mitt Romney displayed nearly all the skills and talents a front-runner might need.

He was able to decimate his leading opponent, former House Speaker Newt Gingrich, through a series of disciplined and sustained attacks, and he had the organizational capacity to press every tactical advantage.

The only thing he failed to do, some critics maintain, was present a convincing case that he's the best possible Republican candidate to take on President Obama.

The first in a three part series on prisoners sentenced to life, new ways to think about the high US high school drop-out rates, the origins of the name of San Francisco's McLaren Park, and jazz great Bobby Hutcherson in his own words.

Former Pennsylvania Sen. Rick Santorum chose to characterize his distant third-place finish in Florida's Republican presidential primary as a victory, of sorts.

"Speaker Gingrich spent 5 or 6 million bucks in the state of Florida and walked away with no delegates," he told NPR after a packed primary night event at his Nevada headquarters in Las Vegas. "I didn't spend a penny."

"We are in a cash-positive position," he said, adding that his campaign on Tuesday raised $200,000 online.

The Food and Drug Administration has approved the first drug that can treat the underlying cause of cystic fibrosis.

The drug, known as Kalydeco, works by helping to fix one defect in the protein that causes the disease.

On a frigid January morning, bundled-up travelers step off a ferry and scurry toward the imposing stone walls of the Haydarpasa train station, a 19th century landmark in Istanbul, a city full of history.

The people boarding this morning are nostalgic. They're longtime station employees, taking one of the last train runs to Eskesihir, where the station's first director-general is buried.

They're going, as it were, to give him bad news — that Haydarpasa's 150-year service as a public transportation center may be coming to an end.

As the Republican candidates were rallying their supporters in Florida on Tuesday night, their campaigns were quietly sending disclosure reports to the Federal Election Commission in Washington. The big picture: Mitt Romney had more money than Newt Gingrich. President Obama had more than either of them. And a few of the new superPACs filed donor lists filled with high rollers.

Tuesday's disclosures run only through Dec. 31 but still reveal some essential truths.

For about two decades, ending in 1971, a former Monsanto chemical plant in West Virginia produced the herbicide 2,4,5-T which was used in "Agent Orange" — the defoliant the military sprayed over Southeast Asia during the Vietnam War.

Now, Monsanto faces a class-action lawsuit, filed on behalf of people living where the herbicide was manufactured in Nitro, W.Va.

The last time the British did this, they had a king: George VI, the father of Queen Elizabeth, was on the throne.

George was so often tongue-tied, yet he proclaimed open the 1948 London Olympics flawlessly.

It was late July. The sun shone down on London from a cloudless sky. The BBC had acquired the TV broadcasting rights for just $4,000 and made the most of them.

People packed Wembley Stadium, eager to forget the horrors of the second world war.